Copyright
©2014 Baishideng Publishing Group Inc.
World J Clin Urol. Nov 24, 2014; 3(3): 152-160
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.152
Published online Nov 24, 2014. doi: 10.5410/wjcu.v3.i3.152
Study | Year | Location | Patient | Outcome |
Urinary diversion/reconstruction for cases of catheter intolerant secondary progressive multiple sclerosis with refractory urinary symptoms[43] | 2011 | Lahey Clinic | 26 MS patients (22 female) 15 ileovesicostomy, 7 enterocystoplasty and 4 ileal loop procedures | Improved continence and fewer UTIs |
Management of neurogenic bladder dysfunction with incontinent ileovesicostomy[34] | 1999 | Wayne State | Thirteen patients incontinent ileovesicostomy 8 SCI, 4 MS, 1 TB Meningitis | Safe and effective at providing low pressure urinary drainage |
Augmentation cystoplasty in patients with multiple sclerosis[38] | 2003 | Czech Republic | 9 MS patients (7 females, 2 males) | Increased detrusor capacity and decreased pressure |
Bladder neck closure and suprapubic catheter placement as definitive management of neurogenic bladder[39] | 2011 | Tulane | 35 patients, 11 male 24 female 27 SCI, 5 MS, 4 other | 97% continent, 8 requiring reprocedure to achieve continence |
Functional outcomes after management of end-stage neurological bladder dysfunction with ileal conduit in a multiple sclerosis population: A monocentric experience[42] | 2011 | France | 53 MS patients, 6 men 47 women | Statistically significant improved QOL |
Robotic-assisted ileovesicostomy: Initial results[36] | 2009 | Lahey | 8 MS patients | Safe and effective with minimal blood loss and shorter LOS |
Prospective evaluation of laparoscopic assisted cystectomy and ileal conduit in advanced multiple sclerosis[41] | 2012 | France | 44 MS patients, 34 women 10 men | Decrease in limitations and constraint scores and an increase in autonomy scores |
A modification to augmentation cystoplasty with catheterizable stoma for neurogenic patients: Technique and long-term results[40] | 2012 | Methodist Hospital | 12 MS patients | Safe and effective, no ureteral reimplants, no need for cystectomy |
- Citation: Parrillo L, Lamin E, Smith A. Non-pharmacologic options for the management of voiding dysfunction in multiple sclerosis. World J Clin Urol 2014; 3(3): 152-160
- URL: https://www.wjgnet.com/2219-2816/full/v3/i3/152.htm
- DOI: https://dx.doi.org/10.5410/wjcu.v3.i3.152